|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q61160187
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010725.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q61160187
|
|
024
|
|
|
‡a
0000-0002-2833-1771
‡2
orcid
|
|
024
|
|
|
‡a
38662293300
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q61160187
|
|
100
|
0 |
|
‡a
Edézio Ferreira Cunha-Junior
‡c
researcher ORCID ID = 0000-0002-2833-1771
‡9
en
|
|
400
|
0 |
|
‡a
Edézio Ferreira Cunha-Junior
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous Leishmaniasis
|
|
670
|
|
|
‡a
Author's Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
|
|
670
|
|
|
‡a
Author's Leishmaniasis treatment: update of possibilities for drug repurposing.
|
|
670
|
|
|
‡a
Author's LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis
|
|
670
|
|
|
‡a
Author's Naphthoquinones and derivatives for chemotherapy: perspectives and limitations of their anti-trypanosomatids activities
|
|
670
|
|
|
‡a
Author's Oral effectiveness of PMIC4, a novel hydroxyethylpiperazine analogue, in Leishmania amazonensis
|
|
670
|
|
|
‡a
Author's Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
|
|
670
|
|
|
‡a
Author's Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis.
|
|
670
|
|
|
‡a
Author's Pterocarpanquinone LQB-118 induces apoptosis in Leishmania
|
|
670
|
|
|
‡a
Author's Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters.
|
|
670
|
|
|
‡a
Author's Pterocarpanquinones, aza-pterocarpanquinone and derivatives: synthesis, antineoplasic activity on human malignant cell lines and antileishmanial activity on Leishmania amazonensis.
|
|
670
|
|
|
‡a
Author's Second-generation pterocarpanquinones: synthesis and antileishmanial activity
|
|
670
|
|
|
‡a
Author's Supercritical Fluid Extraction of Pyrrolidine Alkaloid from Leaves of Piper amalago L.
|
|
670
|
|
|
‡a
Author's The new pyrazolyltetrazole derivative MSN20 is effective via oral delivery against cutaneous leishmaniasis
|
|
670
|
|
|
‡a
Author's The pharmacological inhibition of sterol biosynthesis in Leishmania is counteracted by enhancement of LDL endocytosis
|
|
670
|
|
|
‡a
Author's The Trypanocidal Effect of Novel Quinolines: In vitro And In vivo Studies
|
|
909
|
|
|
‡a
(orcid) 0000000228331771
‡9
1
|
|
909
|
|
|
‡a
(scopus) 38662293300
‡9
1
|
|
919
|
|
|
‡a
pharmacologicalinhibitionofsterolbiosynthesisinleishmaniaiscounteractedbyenhancementofldlendocytosis
‡A
The pharmacological inhibition of sterol biosynthesis in Leishmania is counteracted by enhancement of LDL endocytosis
‡9
1
|
|
919
|
|
|
‡a
newpyrazolyltetrazolederivativemsn20iseffectiveviaoraldeliveryagainstcutaneousleishmaniasis
‡A
The new pyrazolyltetrazole derivative MSN20 is effective via oral delivery against cutaneous leishmaniasis
‡9
1
|
|
919
|
|
|
‡a
2generationpterocarpanquinonessynthesisandantileishmanialactivity
‡A
Second-generation pterocarpanquinones: synthesis and antileishmanial activity
‡9
1
|
|
919
|
|
|
‡a
supercriticalfluidextractionofpyrrolidinealkaloidfromleavesofpiperamalago50
‡A
Supercritical Fluid Extraction of Pyrrolidine Alkaloid from Leaves of Piper amalago L.
‡9
1
|
|
919
|
|
|
‡a
pterocarpanquinonelqb118inducesapoptosisinleishmaniavianniabraziliensisandcontrolslesionsininfectedhamsters
‡A
Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters.
‡9
1
|
|
919
|
|
|
‡a
naphthoquinonesandderivativesforchemotherapyperspectivesandlimitationsoftheirantitrypanosomatidsactivities
‡A
Naphthoquinones and derivatives for chemotherapy: perspectives and limitations of their anti-trypanosomatids activities
‡9
1
|
|
919
|
|
|
‡a
lqb118anorallyactivepterocarpanquinoneinducesselectiveoxidativestressandapoptosisinleishmaniaamazonensis
‡A
LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis
‡9
1
|
|
919
|
|
|
‡a
pterocarpanquinonelqb118inducesapoptosisinleishmania
‡A
Pterocarpanquinone LQB-118 induces apoptosis in Leishmania
‡9
1
|
|
919
|
|
|
‡a
oraleffectivenessofpmic4anovelhydroxyethylpiperazineanalogueinleishmaniaamazonensis
‡A
Oral effectiveness of PMIC4, a novel hydroxyethylpiperazine analogue, in Leishmania amazonensis
‡9
1
|
|
919
|
|
|
‡a
leishmaniasistreatmentupdateofpossibilitiesfordrugrepurposing
‡A
Leishmaniasis treatment: update of possibilities for drug repurposing.
‡9
1
|
|
919
|
|
|
‡a
cyclobenzaprineraisesroslevelsinleishmaniainfantumandreducesparasiteburdenininfectedmice
‡A
Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
‡9
1
|
|
919
|
|
|
‡a
pterocarpanquinonesazapterocarpanquinoneandderivativessynthesisantineoplasicactivityonhumanmalignantcelllinesandantileishmanialactivityonleishmaniaamazonensis
‡A
Pterocarpanquinones, aza-pterocarpanquinone and derivatives: synthesis, antineoplasic activity on human malignant cell lines and antileishmanial activity on Leishmania amazonensis.
‡9
1
|
|
919
|
|
|
‡a
trypanocidaleffectofnovelquinolinesinvitroandinvivostudies
‡A
The Trypanocidal Effect of Novel Quinolines: In vitro And In vivo Studies
‡9
1
|
|
919
|
|
|
‡a
phenotypicevaluationandinsilicoadmetpropertiesofnovelarylimidamidesinacutemousemodelsoftrypanosomacruziinfection
‡A
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
‡9
1
|
|
919
|
|
|
‡a
antileishmanialactivityofezetimibeinhibitionofsterolbiosynthesisinvitrosynergywithazolesandefficacyinexperimentalcutaneousleishmaniasis
‡A
Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous Leishmaniasis
‡9
1
|
|
919
|
|
|
‡a
preclinicalstudiesevaluatingsubacutetoxicityandtherapeuticefficacyoflqb118inexperimentalvisceralleishmaniasis
‡A
Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis.
‡9
1
|
|
996
|
|
|
‡2
BNCHL|10000000000000000215403
|
|
996
|
|
|
‡2
PTBNP|144033
|
|
996
|
|
|
‡2
LC|n 87916587
|
|
996
|
|
|
‡2
PTBNP|156982
|
|
996
|
|
|
‡2
ISNI|0000000109183147
|
|
996
|
|
|
‡2
ISNI|0000000067450322
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
